X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 55 filers reported holding X4 PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $352,989 | -43.8% | 323,843 | 0.0% | 0.00% | – |
| Q2 2023 | $628,255 | +1603.7% | 323,843 | +664.0% | 0.00% | – |
| Q1 2023 | $36,876 | -12.4% | 42,386 | 0.0% | 0.00% | – |
| Q4 2022 | $42,089 | -42.3% | 42,386 | 0.0% | 0.00% | – |
| Q3 2022 | $73,000 | -79.7% | 42,386 | +1.7% | 0.00% | – |
| Q1 2021 | $359,000 | +34.0% | 41,673 | 0.0% | 0.00% | – |
| Q4 2020 | $268,000 | +3.1% | 41,673 | +8.9% | 0.00% | – |
| Q3 2020 | $260,000 | -32.5% | 38,269 | -7.2% | 0.00% | – |
| Q2 2020 | $385,000 | -2.3% | 41,233 | +4.8% | 0.00% | – |
| Q1 2020 | $394,000 | +16.9% | 39,328 | +25.1% | 0.00% | – |
| Q4 2019 | $337,000 | -15.8% | 31,445 | 0.0% | 0.00% | – |
| Q3 2019 | $400,000 | +26.2% | 31,445 | +49.2% | 0.00% | – |
| Q2 2019 | $317,000 | – | 21,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,682,000 | 3.48% |
| Sio Capital Management, LLC | 804,597 | $6,928,000 | 1.41% |
| Bain Capital Life Sciences Investors, LLC | 2,119,540 | $18,249,000 | 1.03% |
| SV Health Investors, LLC | 311,490 | $2,682,000 | 1.00% |
| Monashee Investment Management LLC | 574,712 | $4,948,000 | 0.76% |
| Ikarian Capital, LLC | 2,614,988 | $22,515,000 | 0.76% |
| Abingworth LLP | 229,885 | $1,956,000 | 0.68% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,884,000 | 0.67% |
| BVF INC/IL | 1,091,579 | $9,398,000 | 0.35% |
| Endurant Capital Management LP | 151,996 | $1,309,000 | 0.34% |